iShares U.S. Pharmaceuticals ETF IHE

Medalist Rating as of | See iShares Investment Hub

Morningstar’s Analysis IHE

Will IHE outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

iShares US Pharmaceuticals ETF holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings IHE

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 80.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

25.34 394M
Healthcare

Johnson & Johnson

22.44 349M
Healthcare

Royalty Pharma PLC Class A

4.73 74M
Healthcare

Zoetis Inc Class A

4.69 73M
Healthcare

Pfizer Inc

4.69 73M
Healthcare

Viatris Inc

4.67 73M
Healthcare

Merck & Co Inc

4.23 66M
Healthcare

Bristol-Myers Squibb Co

4.16 65M
Healthcare

Jazz Pharmaceuticals PLC

2.88 45M
Healthcare

Elanco Animal Health Inc

2.45 38M
Healthcare

Sponsor Center